Patents by Inventor Chris De Graaf

Chris De Graaf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-COV-2 MPRO INHIBITOR COMPOUNDS
    Publication number: 20240083845
    Abstract: The disclosures herein relate to compounds of Formula (1?): or a salt thereof, wherein A, Q, X, Z, L, R2, R3 and R9 are defined herein, and their use in the treatment of SARS-CoV-2 and related viruses and disorders associated with SARS-CoV-2: Mpro.
    Type: Application
    Filed: December 20, 2021
    Publication date: March 14, 2024
    Applicant: HEPTARES THERAPEUTICS LIMITED
    Inventors: Miles Stuart CONGREVE, John Andrew CHRISTOPHER, Mark PICKWORTH, Chris DE GRAAF, Alicia Perez HIGUERUELO, Jonathan Stephen MASON, Santosh S. KULKARNI
  • GPR52 MODULATOR COMPOUNDS
    Publication number: 20230002374
    Abstract: The disclosures herein relate to novel compounds of Formula (1): (1) and salts thereof, wherein R1, Q, X, Y and Z are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with GPR52 receptors.
    Type: Application
    Filed: November 9, 2020
    Publication date: January 5, 2023
    Inventors: Sarah Joanne Bucknell, Stephen Paul Watson, Michael Alistair O'Brien, Chris De Graaf, Nigel Alan Swain